MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL)
CUSIP: 558868105
Q1 2017 13F Holders as of 31 Mar 2017
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 22,766,960
- Total 13F shares
- 1,529,190
- Share change
- +196,023
- Total reported value
- $23,547,216
- Price per share
- $15.40
- Number of holders
- 25
- Value change
- +$3,024,176
- Number of buys
- 15
- Number of sells
- 3
Quarterly Holders Quick Answers
What is CUSIP 558868105?
CUSIP 558868105 identifies MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 558868105:
Top shareholders of MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Capital World Investors |
13F
|
Company |
1.9%
|
435,000
|
$6,482,000 | — | 31 Dec 2016 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.5%
|
350,000
|
$5,215,000 | — | 31 Dec 2016 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.77%
|
174,891
|
$2,606,000 | — | 31 Dec 2016 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
0.54%
|
124,000
|
$1,848,000 | — | 31 Dec 2016 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.39%
|
88,917
|
$1,325,000 | — | 31 Dec 2016 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.25%
|
57,762
|
$861,000 | — | 31 Dec 2016 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.25%
|
57,475
|
$856,000 | — | 31 Dec 2016 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
25,605
|
$381,000 | — | 31 Dec 2016 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
0.05%
|
11,195
|
$167,000 | — | 31 Dec 2016 | |
| Paloma Partners Management Co |
13F
|
Company |
0.05%
|
10,781
|
$161,000 | — | 31 Dec 2016 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.01%
|
3,279
|
$49,000 | — | 31 Dec 2016 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
2,088
|
$31,000 | — | 31 Dec 2016 | |
| UBS Group AG |
13F
|
Company |
0%
|
967
|
$14,000 | — | 31 Dec 2016 | |
| BlackRock Fund Advisors |
13F
|
Company |
0%
|
632
|
$9,000 | — | 31 Dec 2016 | |
| BLACKROCK ADVISORS LLC |
13F
|
Company |
0%
|
558
|
$8,000 | — | 31 Dec 2016 | |
| Cutler Group LLC / CA |
13F
|
Company |
0%
|
547
|
$8,000 | — | 31 Dec 2016 | |
| D.A. DAVIDSON & CO. |
13F
|
Company |
0%
|
500
|
$7,000 | — | 31 Dec 2016 | |
| Evercore Wealth Management, LLC |
13F
|
Company |
0%
|
354
|
$5,000 | — | 31 Dec 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
332
|
$5,000 | — | 31 Dec 2016 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
300
|
$4,000 | — | 31 Dec 2016 | |
| Creative Planning |
13F
|
Company |
0%
|
170
|
$3,000 | — | 31 Dec 2016 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
128
|
$2,000 | — | 31 Dec 2016 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
57
|
$1,000 | — | 31 Dec 2016 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0%
|
42
|
$1,000 | — | 31 Dec 2016 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
42
|
$1,000 | — | 31 Dec 2016 | |
| Glen Eagle Advisors, LLC |
13F
|
Company |
0%
|
14
|
$209 | — | 31 Dec 2016 |
Institutional Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) as of Q1 2017
As of 31 Mar 2017,
MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,529,190 shares.
The largest 10 holders included
Capital World Investors, ADAGE CAPITAL PARTNERS GP, L.L.C., Rock Springs Capital Management LP, ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BAKER BROS. ADVISORS LP, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, and GOLDMAN SACHS GROUP INC.
This page lists
25
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2017 vs Q4 2016 Across Filers
Q4 2016 holders
24
Q1 2017 holders
25
Holder diff
1
| Investor | Q4 2016 Shares | Q1 2017 Shares | Share Diff | Share Chg % | Q4 2016 Value $ | Q1 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.